Second hits found in primary Eμ-myc lymphomas
| Mouse no. . | Second hit . | |
|---|---|---|
| p53 disruption . | BCL-2high . | |
| Eμ-myc early | ||
| E1 | + | − |
| E2 | − | + |
| E6 | + | − |
| E7 | + | − |
| E9 | − | − |
| E12 | + | − |
| E4 | ND | ND |
| E5 | ND | ND |
| E8 | ND | ND |
| E11 | ND | ND |
| E3 | ND | ND |
| E10 | ND | ND |
| Eμ-myc late | ||
| L1 | − | + |
| L4 | − | + |
| L5 | − | + |
| L6 | − | + |
| L7 | − | + |
| L8 | − | + |
| L10 | + | − |
| L2 | ND | ND |
| L3 | ND | ND |
| L9 | ND | ND |
| L11 | ND | ND |
| Mouse no. . | Second hit . | |
|---|---|---|
| p53 disruption . | BCL-2high . | |
| Eμ-myc early | ||
| E1 | + | − |
| E2 | − | + |
| E6 | + | − |
| E7 | + | − |
| E9 | − | − |
| E12 | + | − |
| E4 | ND | ND |
| E5 | ND | ND |
| E8 | ND | ND |
| E11 | ND | ND |
| E3 | ND | ND |
| E10 | ND | ND |
| Eμ-myc late | ||
| L1 | − | + |
| L4 | − | + |
| L5 | − | + |
| L6 | − | + |
| L7 | − | + |
| L8 | − | + |
| L10 | + | − |
| L2 | ND | ND |
| L3 | ND | ND |
| L9 | ND | ND |
| L11 | ND | ND |
+ or − indicates presence or absence, respectively, of indicated second hit; and ND, absence of appropriate tumor material for immunoblotting.